JOEL GRUBBS: Open Payments
NPI 1649347501 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 62 payments from 14 companies in 2025. Trend: 2023 $1,303 · 2024 $1,219 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $236 |
| PFIZER INC. | 9 | $173 |
| AstraZeneca Pharmaceuticals LP | 6 | $170 |
| Novo Nordisk Inc | 11 | $161 |
| Lilly USA, LLC | 8 | $120 |
| Aimmune Therapeutics, Inc. | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Exact Sciences Corporation | 2 | $35 |
| Antares Pharma, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $28 |
Products named: AIRSUPRA, MOUNJARO, LINZESS, NURTEC ODT, PREVNAR 20, Ozempic, VRAYLAR, Wegovy.
Industry payments across OK — which companies pay providers there.
